{"ticker": {"uuid": "289c928a-f260-4b49-95af-ad90b820b452", "symbol": "688050", "name": "Eyebright Medical Technology (Beijing) Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "ETFs Investing in Eyebright Medical Technology (Beijing) Co., Ltd. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5ybHF3RkZDckFtaG83bzVsbWp1QkpwamREMmdyZzI0c1dGZm1WcGpsb0tVOEFYdC1PalpMY0FoM0JfTnYxckNGcWN4RUxzQmM5Qng3Z0owbldHVVBjS0swcWZR?oc=5", "source_name": "TradingView", "published_at": "2026-07-21T09:46:27+00:00", "published_display": "21 Jul 2026 09:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eyebright Medical Published its 2024 Environmental, Social and Governance Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPRDJoV0xxRFhxV0Y0WjVrRE1qMTlLc1hLRTFaMm9wc3lpemNKMGZsTkI4UVhUNHE0UndIWXlCcWxEcXFhOFNheDRuSFVIZXdTODJRUGhxNFIyVVIyRU1CblZlYlN1LWgyRXRFSTVCR2lzNnVjRnJ6Z0tpYkpjY2dyaTdxdHdBMW16QnIwYTl3Um8tNkVnb01NQ1hoMTFYT0dZWnh3SnNYX25WUHExZF90TmhiUFBaOC1Yb2xFQjVLSHhwRE1YVzlXOHlaZF82LXhTSVZOMGotcw?oc=5", "source_name": "PR Newswire", "published_at": "2025-04-23T07:00:00+00:00", "published_display": "23 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eyebright Medical Receives NMPA Class III Certificate for its Ph", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxNX2wzZklrR3FTRDAtazVTdFQybXFEZEQ5Q093SXRxWTlheER0WXBlQlBVemhhQ2dnRUE3SV9HQ19pVkgxanZNenI5Ny1VZGRMclo3S1FYUExPWUZzUHUyNG9rNDEtN0xyUnFKcUZxNnZ3YlhBR28yb2dscElIZFhzYXdwMERjMDdvbTlYNU5oRm5oODllSFFqR2o0Wm41NFV1TWJpYzg3ZmNZZENscEt4MmxIbnlwbXFYOGRMYnQwdUp1SlQ2QVp0N0s3ZGR2M2JHRC1pejlSSDVhMmtGM2U4MTFUU2J6MlZiR012aTFCdldsZG1xS1lV?oc=5", "source_name": "GuruFocus", "published_at": "2025-01-07T08:00:00+00:00", "published_display": "07 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eyebright Medical Continues to Employ Its Internationalization Strategy: Signed Memorandum with Invest Hong Kong and Spotlight at ESCRS 2024", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwJBVV95cUxPa1FIbkxlWmU3VlBhcW5RXzFHc1ZSNWc1VHBHZGRUWngxOWNmeE13YjZLTzhXSkNHd0czaXhNMTJZMTRMbTMzRUlwcU1TVXlSMVVaUXZ5TVdqRFNvZUpzWGtTU1BhMjhHbTAzWU5mTFE2M0tZT3pKT2YwVlgwTm5UZ0hxcUhxejBCYzRZdmFFNGhZX3p6YlhlaEVHNEo4bzI0OHJTRkpxcWRwaTRod1BHNmJLcEZnWDd4bFFwVFRTVHQ1SXQ5c0xHWkRUS0hMVWxlRlo2aTZqdWlFUHJzR3Bla1p3NFJUY2Q5Ynl2TFVNUUI5MEl2Tjc5bk1NUEF2OHZuNm5Ec3drMGJwUkJUUW1GRjhyUEVnbWFxdW1velpXamVoLWRmaVFj?oc=5", "source_name": "PR Newswire", "published_at": "2024-09-24T07:00:00+00:00", "published_display": "24 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "ETFs Investing in Eyebright Medical Technology (Beijing) Co., Ltd. Class A Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYkFVX3lxTE5ybHF3RkZDckFtaG83bzVsbWp1QkpwamREMmdyZzI0c1dGZm1WcGpsb0tVOEFYdC1PalpMY0FoM0JfTnYxckNGcWN4RUxzQmM5Qng3Z0owbldHVVBjS0swcWZR?oc=5", "source_name": "TradingView", "published_at": "2026-07-21T09:46:27+00:00", "published_display": "21 Jul 2026 09:46", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eyebright Medical Published its 2024 Environmental, Social and Governance Report", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPRDJoV0xxRFhxV0Y0WjVrRE1qMTlLc1hLRTFaMm9wc3lpemNKMGZsTkI4UVhUNHE0UndIWXlCcWxEcXFhOFNheDRuSFVIZXdTODJRUGhxNFIyVVIyRU1CblZlYlN1LWgyRXRFSTVCR2lzNnVjRnJ6Z0tpYkpjY2dyaTdxdHdBMW16QnIwYTl3Um8tNkVnb01NQ1hoMTFYT0dZWnh3SnNYX25WUHExZF90TmhiUFBaOC1Yb2xFQjVLSHhwRE1YVzlXOHlaZF82LXhTSVZOMGotcw?oc=5", "source_name": "PR Newswire", "published_at": "2025-04-23T07:00:00+00:00", "published_display": "23 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eyebright Medical Receives NMPA Class III Certificate for its Ph", "summary": "", "url": "https://news.google.com/rss/articles/CBMi9wFBVV95cUxNX2wzZklrR3FTRDAtazVTdFQybXFEZEQ5Q093SXRxWTlheER0WXBlQlBVemhhQ2dnRUE3SV9HQ19pVkgxanZNenI5Ny1VZGRMclo3S1FYUExPWUZzUHUyNG9rNDEtN0xyUnFKcUZxNnZ3YlhBR28yb2dscElIZFhzYXdwMERjMDdvbTlYNU5oRm5oODllSFFqR2o0Wm41NFV1TWJpYzg3ZmNZZENscEt4MmxIbnlwbXFYOGRMYnQwdUp1SlQ2QVp0N0s3ZGR2M2JHRC1pejlSSDVhMmtGM2U4MTFUU2J6MlZiR012aTFCdldsZG1xS1lV?oc=5", "source_name": "GuruFocus", "published_at": "2025-01-07T08:00:00+00:00", "published_display": "07 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Eyebright Medical Continues to Employ Its Internationalization Strategy: Signed Memorandum with Invest Hong Kong and Spotlight at ESCRS 2024", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwJBVV95cUxPa1FIbkxlWmU3VlBhcW5RXzFHc1ZSNWc1VHBHZGRUWngxOWNmeE13YjZLTzhXSkNHd0czaXhNMTJZMTRMbTMzRUlwcU1TVXlSMVVaUXZ5TVdqRFNvZUpzWGtTU1BhMjhHbTAzWU5mTFE2M0tZT3pKT2YwVlgwTm5UZ0hxcUhxejBCYzRZdmFFNGhZX3p6YlhlaEVHNEo4bzI0OHJTRkpxcWRwaTRod1BHNmJLcEZnWDd4bFFwVFRTVHQ1SXQ5c0xHWkRUS0hMVWxlRlo2aTZqdWlFUHJzR3Bla1p3NFJUY2Q5Ynl2TFVNUUI5MEl2Tjc5bk1NUEF2OHZuNm5Ec3drMGJwUkJUUW1GRjhyUEVnbWFxdW1velpXamVoLWRmaVFj?oc=5", "source_name": "PR Newswire", "published_at": "2024-09-24T07:00:00+00:00", "published_display": "24 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 43, "total_relevant": 4, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 4, "score": 50, "total": 4, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 80, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 41.27, "latest_week": "2026-07-17", "one_week_move": -0.7, "four_week_move": 6.1, "twelve_week_move": -21.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.499909, "market_dynamics_buy_signal": false, "relative_strength": -28.269427, "fair_value_gap": -58.5, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 43.0961, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.7% over one week, +6.1% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 48, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "PR Newswire", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "GuruFocus", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 4}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "80/100 classification confidence."}, {"label": "Company focus", "value": "4", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.7% over one week, +6.1% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "ETFs Investing in Eyebright Medical Technology (Beijing) Co., Ltd. Class A Stocks"}], "updated_at": "2026-07-21T23:08:49.784749+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}